Human gene patents: core issues in a multi-layered debate.

Area of Science:

• Biotechnology Law
• Bioethics
• Intellectual Property

Background:

• Directive 98/44/EG on legal protection of biotechnological inventions adopted in 1998 after a decade of debate.
• The directive addresses controversial bioethical and legal issues, aiming to foster European biotech industry growth.
• However, it leaves several philosophical and moral questions unresolved, particularly concerning genetic material.

Purpose of the Study:

• To analyze the layers and argumentation within the debate surrounding Directive 98/44/EG.
• To identify major philosophical, ethical, and conceptual issues related to the patenting of biotechnological inventions.
• To explore the implications for patenting human DNA and the need for further ethical and legal clarification.

Main Methods:

• Distinguishing different layers within the debate on biotechnological inventions.
• Mapping the modes of argumentation employed in the discussion.
• Locating key philosophical, ethical, and conceptual challenges.

Main Results:

• The directive provides a framework but leaves significant bioethical and legal questions open.
• Key philosophical and ethical issues surrounding patenting, especially of human DNA, persist.
• The special status of genetic material and its connection to personal identity remain unclear.

Conclusions:

• Further analysis of the identified issues can help resolve ethical and legal challenges in patenting human DNA.
• Clarifying the status of human DNA and its relationship to the human body and personal identity is crucial.
• The directive's impact necessitates ongoing ethical and legal discourse on biotechnological innovations.